Skip to main content

EUROPEAN REGIMEN ACCELERATOR FOR TUBERCULOSIS

Project description

Helping to end all forms of TB

In 2018 alone, about 10 million people became ill with tuberculosis (TB) globally and 1.5 million people died from it, placing this disease among the top 10 causes of death in the world. According to the WHO, about one fourth of the global population has been infected by Mycobacterium tuberculosis, although most infected individuals are asymptomatic. About 5-15 % of those infected develop tuberculosis and can transmit the disease. The standard TB treatment requires a 6-month course and involves the combination of several antimicrobial drugs, what makes the access and adherence to the treatment complicated. The TB epidemic has become even more serious with the rise of multidrug-resistant tuberculosis (MDR-TB) and the emergence of extensively drug-resistant TB (XDR-TB). Only half of the patients with MDR-TB are successfully treated, whereas those with XDR-TB type have few treatment options. The EU-funded project ERA4TB is accelerating development of highly active oral drugs with shortened treatment durations to help end all forms of TB by 2030.

Call for proposal

H2020-JTI-IMI2-2018-15-two-stage
See other projects for this call

Funding Scheme

IMI2-RIA - Research and Innovation action

Coordinator

UNIVERSIDAD CARLOS III DE MADRID
Address
Calle Madrid 126
28903 Getafe (Madrid)
Spain
Activity type
Higher or Secondary Education Establishments
EU contribution
€ 5 804 800

Participants (30)

INSTITUT PASTEUR
France
EU contribution
€ 12 003 900
Address
Rue Du Docteur Roux 25-28
75724 Paris Cedex 15
Activity type
Research Organisations
UNIVERSIDAD DE ZARAGOZA
Spain
EU contribution
€ 4 247 900
Address
Calle Pedro Cerbuna 12
50009 Zaragoza
Activity type
Higher or Secondary Education Establishments
INSTITUT PASTEUR DE LILLE FONDATION
France
EU contribution
€ 2 853 750
Address
Rue Du Professeur Calmette 1
59019 Lille
Activity type
Research Organisations
SYNAPSE RESEARCH MANAGEMENT PARTNERS SL
Spain
EU contribution
€ 1 677 500
Address
Calle Velazquez 94 Planta 1
28006 Madrid
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
FORSCHUNGSZENTRUM BORSTEL
Germany
EU contribution
€ 2 287 500
Address
Parkallee 1-40
23845 Borstel
Activity type
Research Organisations
FONDATION INNOVATIVE MEDICINES FOR TUBERCULOSIS (IM4TB)
Switzerland
EU contribution
€ 22 407 250
Address
Epfl Innovation Park Batiment I
1015 Lausanne
Activity type
Other
CRITICAL PATH INSTITUTE, LIMITED
Ireland
EU contribution
€ 3 557 500
Address
33 Sir John Rogerson's
2 Dublin
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
CONSIGLIO NAZIONALE DELLE RICERCHE
Italy
EU contribution
€ 2 443 750
Address
Piazzale Aldo Moro 7
00185 Roma
Activity type
Research Organisations
COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES
France
EU contribution
€ 2 012 500
Address
Rue Leblanc 25
75015 Paris 15
Activity type
Research Organisations
SERVICIO MADRILENO DE SALUD
Spain
EU contribution
€ 16 997 500
Address
Plaza Carlos Trias Bertran 7
28020 Madrid
Activity type
Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
UPPSALA UNIVERSITET
Sweden
EU contribution
€ 1 797 500
Address
Von Kraemers Alle 4
751 05 Uppsala
Activity type
Higher or Secondary Education Establishments
Department of Health
United Kingdom
EU contribution
€ 1 557 500
Address
Quarry House, Quarry Hill
LS2 7UE Leeds
Activity type
Research Organisations
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE
Switzerland
EU contribution
€ 962 500
Address
Batiment Ce 3316 Station 1
1015 Lausanne
Activity type
Higher or Secondary Education Establishments
KLINIKUM DER UNIVERSITAET ZU KOELN
Germany
EU contribution
€ 1 407 500
Address
Kerpener Strasse 62
50937 Koeln
Activity type
Higher or Secondary Education Establishments
UNIVERSITA DEGLI STUDI DI PADOVA
Italy
EU contribution
€ 615 000
Address
Via 8 Febbraio 2
35122 Padova
Activity type
Higher or Secondary Education Establishments
UNIVERSITA DEGLI STUDI DI PAVIA
Italy
EU contribution
€ 592 000
Address
Strada Nuova 65
27100 Pavia
Activity type
Higher or Secondary Education Establishments
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE
United Kingdom
EU contribution
€ 293 500
Address
Level 1A City Tower Piccadilly Plaza
M1 4BT Manchester
Activity type
Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
IMABIOTECH SAS
France
EU contribution
€ 837 500
Address
152 Rue Du Docteur Yersin
59120 Loos
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
SCIENSANO
Belgium
EU contribution
€ 1 637 500
Address
Juliette Wytsmanstraat 14
1050 Elsene
Activity type
Research Organisations
LATVIJAS ORGANISKAS SINTEZES INSTITUTS
Latvia
EU contribution
€ 277 500
Address
Aizkraukles 21
1006 Riga
Activity type
Research Organisations
BIOASTER FONDATION DE COOPERATION SCIENTIFIQUE
France
EU contribution
€ 1 856 250
Address
40 Avenue Tony Garnier
69007 Lyon
Activity type
Research Organisations
QPS NETHERLANDS BV
Netherlands
EU contribution
€ 277 500
Address
Hanzeplein 1, Ingang 53
9713 GZ Groningen
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
LUNDS UNIVERSITET
Sweden
EU contribution
€ 277 500
Address
Paradisgatan 5C
22100 Lund
Activity type
Higher or Secondary Education Establishments
GRITSYSTEMS AS
Denmark
EU contribution
€ 1 132 500
Address
Trekronergade 126F, 3 Tv
2500 Valby
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
GLAXOSMITHKLINE INVESTIGACION Y DESARROLLO SL
Spain
EU contribution
€ 0
Address
C/ Severo Ochoa Numero 2 Parque Tecnologico De Madrid
28760 Tres Cantos
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
EVOTEC INTERNATIONAL GMBH
Germany
EU contribution
€ 0
Address
Essener Bogen 7
22419 Hamburg
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
JANSSEN PHARMACEUTICA NV
Belgium
EU contribution
€ 0
Address
Turnhoutseweg 30
2340 Beerse
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
BILL & MELINDA GATES FOUNDATION
United States
EU contribution
€ 0
Address
500 5Th Ave N
98102 Seattle, Washington
Activity type
Research Organisations
GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT NON PROFIT ORGANISATION
United States
EU contribution
€ 0
Address
Wall Street 40 24Th Floor
10005 New York
Activity type
Research Organisations
UNIVERSITY OF DUNDEE
United Kingdom
EU contribution
€ 0
Address
Nethergate
DD1 4HN Dundee
Activity type
Higher or Secondary Education Establishments